Visionary Or Bottleneck: When Founder Traits Affect Startup Outcomes
Management Practice Insights · 2025
DOI: 10.59571/mpi.v3i2.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Management Practice Insights, 2025. Verfasst von Ashneet Kaur.
Abstract (Originalsprache)
Research shows that a founder's personality can significantly affect a firm's success.1 Many startup founders are often celebrated for being visionary, driven and relentless.2 But what happens when the same traits start to erode team trust, stunt collaboration or push the venture into chaos? This is especially relevant in high-stakes, fast-growth environments where agility is prized, but internal dissent is quietly suppressed. Founders with bold visions may override uncomfortable feedback, build echo chambers or stretch resources without restraint. Industry analyses highlight that strong leadership traits often correlate with increased profitability and innovation, suggesting that founder personality is not just a leadership style, but a business driver.3 So, how can founders walk this tightrope and how can investors or early team members spot the tipping points before it's too late? Research by Katrina M. Brownell, Audra Quinn and Mark T. Bolinger shows that traits like Machiavellianism (strategic manipulation), narcissism (excessive self-belief) and psychopathy (emotional detachment) don't always doom a startup.4 These traits often catalyze growth when channelled well. The trick lies in balancing ambition with humility, decisiveness with transparency, and control with collaboration to transform potential liabilities into lasting strengths5
Zitieren
APA
Kaur, A. (2025). Visionary Or Bottleneck: When Founder Traits Affect Startup Outcomes. Management Practice Insights. https://doi.org/10.59571/mpi.v3i2.1
Vancouver
Kaur A. Visionary Or Bottleneck: When Founder Traits Affect Startup Outcomes. Management Practice Insights. 2025. doi:10.59571/mpi.v3i2.1
BibTeX
@article{Kaur2025,
author = {Kaur, Ashneet},
title = {Visionary Or Bottleneck: When Founder Traits Affect Startup Outcomes},
journal = {Management Practice Insights},
year = {2025},
doi = {10.59571/mpi.v3i2.1}
}
EUVIMED